+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Germany Women Health Diagnostics Market 2019-2025

  • PDF Icon

    Report

  • March 2020
  • Region: Germany
  • Orion Market Research Private Limited
  • ID: 5124692
UP TO OFF until Dec 31st 2022
Germany Women Health Diagnostics Market Size, Share & Trends Analysis Report by Application (Breast Cancer Testing, Cervical Cancer Testing, Pregnancy & Fertility Testing, Ovarian Cancer Testing, Infectious Disease Testing, Ultrasound Tests, Sexually Transmitted Disease Testing, and Others (Osteoporosis Testing and Prenatal Genetic Testing)), and by End-User (Diagnostic and Imaging Centers, Hospitals and Clinics, and Home Care) Forecast Period 2019-2025.

Germany women health diagnostics market is growing at a CAGR of approximately 9.4% during the forecast period. Germany is expected to grow owing to various factors including government support towards women health. Health insurance is one of the major guidelines enforced by the government of Germany, health insurance is mandatory for all citizens and permanent residents of Germany, which is expected to increase the Germany women health diagnostic during the forecast period. It is provided by two systems, that is competing, not-for-profit, nongovernmental health insurance funds in the statutory health insurance (SHI) system and substitutive private health insurance (PHI). States own most university hospitals, while municipalities play a role in public health activities and own about half of all hospital beds. Though, the various levels of government have virtually no role in the direct financing or delivery of health care. This health insurance insures the women in any critical illness such as cancer, STDs and many others. Thus, such initiatives and programs by the government are projected to propel the growth of the Germany women health diagnostic market.

Further, for various screening and tests including cancer and contraception, the government provides various facilities for women in the region. For instance, for cancer screening, every woman over the age of 20, both state-funded and private health insurance in Germany covers an annual exam at the gynecologist for the checkup for early symptoms of cervical cancer, ovary cancer, breast cancer, and any other reproductive related cancer. Whereas, for contraception, all usual methods of contraception are given, though, hormonal contraceptives (the birth control pill, implants, injections), IUDs (intra-uterine devices such as the spiral) are prescribed by a gynecologist. Hence, the availability of such options contributes to enhancing women health and in turn aids in the growth of the Germany women health diagnostic market.

Research Methodology

The market study of the Germany Women Health Diagnostics market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors.

Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

1. Germany Women Health Diagnostics Market Research and Analysis by Application
2. Germany Women Health Diagnostics Market Research and Analysis by End-user

The Report covers:
  • Comprehensive research methodology of the Germany Women Health Diagnostics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Germany Women Health Diagnostics market.
  • Insights about market determinants which are stimulating the Germany Women Health Diagnostics market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Germany Women Health Diagnostics Market by Application
5.1.1. Breast Cancer Testing
5.1.2. Cervical Cancer Testing
5.1.3. Pregnancy & Fertility Testing
5.1.4. Ovarian Cancer Testing
5.1.5. Infectious Disease Testing
5.1.6. Ultrasound Tests
5.1.7. Sexually Transmitted Disease Testing
5.1.8. Others (Osteoporosis Testing and Prenatal Genetic Testing)
5.2. Germany Women Health Diagnostics Market by End-User
5.2.1. Diagnostic and Imaging Centers
5.2.2. Hospitals and Clinics
5.2.3. Home Care
6. Company Profiles
6.1. Abbott Laboratories, Inc.
6.2. Becton, Dickson and Co.
6.3. biomerieux SA
6.4. EKF Diagnostics Holdings PLC
6.5. F. Hoffmann-La Roche Ltd.
6.6. Fujifilm Holdings Corp.
6.7. General Electric Co.
6.8. Hologic, Inc.
6.9. Koninklijke Philips N.V.
6.10. Nova Biomedical Pte. Ltd.
6.11. QIAGEN N.V.
6.12. Siemens AG
6.13. Thermo Fisher Scientific Inc.
LIST OF TABLES
1. GERMANY WOMEN HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
2. GERMANY WOMEN HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
LIST OF FIGURES
1. GERMANY WOMEN HEALTH DIAGNOSTICS MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)
2. GERMANY WOMEN HEALTH DIAGNOSTICS MARKET SHARE BY END-USER, 2018 VS 2025 (%)

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories, Inc.
  • Becton, Dickson and Co.
  • biomerieux SA
  • EKF Diagnostics Holdings PLC
  • F. Hoffmann-La Roche Ltd.
  • Fujifilm Holdings Corp.
  • General Electric Co.
  • Hologic, Inc.
  • Koninklijke Philips N.V.
  • Nova Biomedical Pte. Ltd.
  • QIAGEN N.V.
  • Siemens AG
  • Thermo Fisher Scientific Inc.